BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7216702)

  • 1. The effect of certain variables on the tumor and tissue distribution of tracers. III. Salicylates and vasoactive drugs.
    Halpern SE; Hagan P; Stern P; Gordon R; Dabbs J
    Invest Radiol; 1981; 16(2):120-5. PubMed ID: 7216702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of certain variables on the tumor and tissue distribution of tracers. IV. False carriers: ferric citrate.
    Hagan PL; Halpern SE; Stern P; Dabbs J; Gordon R
    Invest Radiol; 1981; 16(3):229-33. PubMed ID: 7263158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of certain variables on the tumor and tissue distribution of tracers. Part 1; Carrier.
    Halpern SE; Hagan PL; Chauncey D; McKegney M; Bernstein K
    Invest Radiol; 1979; 14(6):482-92. PubMed ID: 528167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of certain variables on the tumor and tissue distribution of tracers. II. Carrier effect: rapidity of onset and concentrations necessary for initiation and maximum response.
    Hagan PL; Halpern SE; Stern P; Dabbs J; Gordon R
    Invest Radiol; 1980; 15(6):496-501. PubMed ID: 7203904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of certain variables on the tumor and tissue distribution of tracers V: false carrier effect, II, Fe.
    Hagan PL; Halpern SE; Stern PH; Gordon RM; Dabbs JE
    Invest Radiol; 1982; 17(1):53-60. PubMed ID: 7076435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallium-67 uptake by hepatoma: studies in cell cultures, perfused livers, and intact rats.
    Scheffel U; Wagner HN; Klein JL; Tsan MF
    J Nucl Med; 1985 Dec; 26(12):1438-44. PubMed ID: 3864944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of 67Ga-6-mercaptopurines in Morris hepatoma-3924 A.
    Guarino A; Shukla SK; Castelli L; Cipriani C; Manni GB
    Eur J Nucl Med; 1979 Jun; 4(3):211-5. PubMed ID: 499242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of certain variables on the tumor and tissue distribution of tracers: VI. False-carrier effect, Part III, Fe.
    Stern PH; Halpern SE; Hagan PL; Chen A
    Invest Radiol; 1982; 17(4):386-93. PubMed ID: 7129820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anemia in malignant tumor diseases. I. Tumor-induced loss of transferrin and its relation to tumor size and degree of malignancy in the rat model].
    Aulbert E
    Nuklearmedizin; 1989 Oct; 28(5):193-200. PubMed ID: 2813083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor and liver uptake models of 67Ga-citrate.
    Ando A; Ando I; Sanada S; Hiraki T; Hisada K
    Eur J Nucl Med; 1985; 10(5-6):262-8. PubMed ID: 3157569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor model studies of 131I-tetracycline and other compounds.
    Chauncey DM; Halpern SE; Hagan PL; Alazraki NP
    J Nucl Med; 1976 Apr; 17(4):274-81. PubMed ID: 1255253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of 67Ga uptake to citrate dose, compared with 67Ga-chloride and 67Ga-transferrin in rodent tissues and tumours.
    Hammersley PA; Zivanovic MA
    Nuklearmedizin; 1980 Feb; 19(1):25-8. PubMed ID: 7402941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new tumor imaging agent--111In-bleomycin complex. Comparison with 67Ga-citrate and 57Co-bleomycin in tumor-bearing animals.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Miller EE; Larson SM
    J Surg Oncol; 1984 Nov; 27(3):189-95. PubMed ID: 6208427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution of 67Ga-citrate in 3'-methyl-4-dimethylaminoazobenzene-induced hepatoma of rats].
    Morita S; Kikuchi S; Nishi F; Okinaga T; Moriguchi Y; Bussaka Y; Umezaki N; Yano K; Ohtake H; Kojiro M; Kawasaki H
    Radioisotopes; 1982 Sep; 31(9):459-62. PubMed ID: 6818620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of viable and nonviable tumor uptake of Sc-46, Mn-54, Zn-65, In-111 and Au-195 with Ga-67 citrate in a hepatoma model.
    Hagan PL; Chauncey DM; Halpern SE; McKegney ML
    Eur J Nucl Med; 1977 Dec; 2(4):225-30. PubMed ID: 204486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of gallium distribution in the rat using periodically related elements: enhanced early imaging.
    Triplett JW; Bourne DW; Kim EE; Gautam SR; McWhorter LK; Deland FH
    Acta Radiol Oncol; 1981; 20(6):365-71. PubMed ID: 6278859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vasoactive agents on the dermatopharmacokinetics and systemic disposition of model compounds, salicylate and FITC-dextran 4 kDa, following intracutaneous injection of the compounds.
    Yoshida D; Todo H; Hasegawa T; Sugibayashi K
    Int J Pharm; 2008 May; 356(1-2):181-6. PubMed ID: 18294788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of gallium-67 in normal and hypotransferrinemic tumor-bearing mice.
    Sohn MH; Jones BJ; Whiting JH; Datz FL; Lynch RE; Morton KA
    J Nucl Med; 1993 Dec; 34(12):2135-43. PubMed ID: 8254401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor uptake of 67Ga-carrying liposomes.
    Ogihara I; Kojima S; Jay M
    Eur J Nucl Med; 1986; 11(10):405-11. PubMed ID: 3699065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution of DL-lactic acid-1[14C] in tumor-bearing rats.
    Chandra R; Freed BR
    Int J Nucl Med Biol; 1979; 6(2):122-3. PubMed ID: 478766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.